Fidelity Management & Research Co.

Other nine-digit financings go to Airna, Atsena, Neurona

Maraganore’s latest RNA company pairs targeting tech with trigger molecules a fraction of the size of Alnylam’s

BioCentury’s latest Venture Report includes rounds for Judo, Purespring, Basecamp, Arda and more

BioCentury’s latest Venture Report also features news about LoQus23, Aktis, Resolution, Triveni, Flagship and more

Plus: Rounds for Radiant, Vironexis, Bambusa, OrsoBio and F2G

Ken Song’s post-RayzeBio venture pulled together two licensing deals, an M&A transaction and three financings totaling $370M 

Plus: New capital for CytoReason, Truvian and Renalys

Plus: Big rounds for Element, Beacon and Myricx

Plus: Early-stage financings for InduPro, Syntis and Moleculent; J.P. Morgan closes its life sciences vehicle; and a new fund for spinal injury

Plus rounds for Rubedo, Flindr, Endeavor, SynOx and more